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Shared decision making in patients with low risk chest pain: 
prospective randomized pragmatic trial
Erik P Hess,1,2,3 Judd E Hollander,4 Jason T Schaffer,5 Jeffrey A Kline,5 Carlos A Torres,6 Deborah B Diercks,7 
Russell Jones,8 Kelly P Owen,8 Zachary F Meisel,9 Michel Demers,10 Annie Leblanc,2,11 Nilay D Shah,11 
Jonathan Inselman,3 Jeph Herrin,13 Ana Castaneda-Guarderas,1,2,14 Victor M Montori2,15 
ABSTRACT
ObjeCtive
To compare the effectiveness of shared decision 
making with usual care in choice of admission for 
observation and further cardiac testing or for referral 
for outpatient evaluation in patients with possible 
acute coronary syndrome.
Design
Multicenter pragmatic parallel randomized controlled 
trial.
setting
Six emergency departments in the United States.
PartiCiPants
898 adults (aged >17 years) with a primary complaint 
of chest pain who were being considered for admission 
to an observation unit for cardiac testing (451 were 
allocated to the decision aid and 447 to usual care), 
and 361 emergency clinicians (emergency physicians, 
nurse practitioners, and physician assistants) caring 
for patients with chest pain.
interventiOns
Patients were randomly assigned (1:1) by an electronic, 
web based system to shared decision making 
facilitated by a decision aid or to usual care. The 
primary outcome, selected by patient and caregiver 
advisers, was patient knowledge of their risk for acute 
coronary syndrome and options for care; secondary 
outcomes were involvement in the decision to be 
admitted, proportion of patients admitted for cardiac 
testing, and the 30 day rate of major adverse cardiac 
events.
results
Compared with the usual care arm, patients in the 
decision aid arm had greater knowledge of their risk 
for acute coronary syndrome and options for care 
(questions correct: decision aid, 4.2 v usual care, 3.6; 
mean difference 0.66, 95% confidence interval 0.46 to 
0.86), were more involved in the decision (observing 
patient involvement scores: decision aid, 18.3 v usual 
care, 7.9; 10.3, 9.1 to 11.5), and less frequently decided 
with their clinician to be admitted for cardiac testing 
(decision aid, 37% v usual care, 52%; absolute 
difference 15%; P<0.001). There were no major adverse 
cardiac events due to the intervention.
COnClusiOns
Use of a decision aid in patients at low risk for acute 
coronary syndrome increased patient knowledge 
about their risk, increased engagement, and safely 
decreased the rate of admission to an observation unit 
for cardiac testing.
trial registratiOn
ClinicalTrials.gov NCT01969240.
Introduction
Chest pain is the second most common reason people 
visit emergency departments for evaluation, accounting 
for over eight million visits annually in the United States1 
and an estimated 360 000 attendances in England and 
Wales.2  Over the past decade the proportion of visits to 
an emergency department for chest pain decreased by 
10% and the proportion of patients with a diagnosis of 
acute coronary syndrome in the emergency setting 
decreased from 26% to 13%. Despite the decreasing inci-
dence of acute coronary syndrome, advanced cardiac 
imaging for chest pain has increased nearly fourfold.3
Current clinical, electrocardiographic, and labora-
tory data do not identify all patients with acute coro-
nary syndrome who present to the emergency 
department, resulting in a 1.5% miss rate.4  Given the 
potential medical, legal, and psychological sequelae 
associated with missing such a diagnosis, clinicians 
have a low threshold to admit patients for prolonged 
observation and advanced cardiac testing.5  As a conse-
quence, low risk patients are often admitted for obser-
vation and cardiac stress testing or coronary computed 
tomography angiography (CCTA). This results in 
 unnecessary hospital admissions,6  false positive test 
results, and unnecessary invasive downstream investi-
gations, at an estimated cost to the healthcare system of 
over $7b (£5.6b; €6.5b) annually.7
To assist clinicians, and patients with possible acute 
coronary syndrome in making risk informed shared 
WhAT IS AlReAdy knoWn on ThIS TopIC
Current clinical, electrocardiographic, and laboratory tests miss about 1.5% of 
patients with acute coronary syndrome
Given the potential for missed diagnosis, clinicians have a low risk threshold to 
admit patients for observation and advanced cardiac testing, leading to false 
positive test results, unnecessary downstream procedures, and increased cost to 
patients and the healthcare system
Evidence for the effectiveness, safety, and acceptability of a shared decision 
making approach to communicate risk to patients and engage them in decisions 
about testing and follow up is limited
WhAT ThIS STudy AddS
Use of a decision aid increased patient knowledge and engagement, decreased 
decisional conflict and the rate of admission to an observation unit for advanced 
cardiac testing, and was acceptable to patients and clinicians
Translating validated risk estimates to practice and engaging patients in care 
decisions through shared decision making might tailor testing to disease risk in a 
way that is acceptable to patients, clinicians, and policy makers
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decisions about testing and follow-up, we included 
 validated8 9  45 day risk estimates for acute coronary 
syndrome into a decision aid, “chest pain choice.”10 
In a single center pilot randomized trial of this decision 
aid, we observed increased patient knowledge about 
risk of acute coronary syndrome, increased patient 
engagement, decreased decisional conflict, and a 19% 
lower rate of admission to an observation unit for car-
diac stress testing in the decision aid compared with the 
usual care arm, with no adverse events in either study 
arm.11  This pilot randomized trial was conducted in a 
single tertiary care academic emergency department in 
the central United States. To test the effectiveness of the 
decision aid to improve patient knowledge and decrease 
unnecessary resource use in a broader population of 
patients with greater socioeconomic diversity and in a 
variety of clinical contexts, we conducted a multicenter 
pragmatic12 randomized trial in six geographically 
diverse emergency departments across the United 
States.
Methods
study design
The background and methods of the trial have been 
described previously.13  This was a pragmatic parallel 
randomized controlled trial in low risk patients present-
ing to the emergency department with a potential acute 
coronary syndrome. The trial compared an intervention 
group receiving a structured risk assessment using a 
quantitative pretest probability web tool14  and corre-
sponding decision aid with a control group receiving 
usual care.15 Patients and clinicians were enrolled from 
the emergency departments at six US sites (University of 
California Davis on the west coast, Mayo Clinic Roches-
ter and Indiana University in central US, University of 
Pennsylvania and Thomas Jefferson University on the 
east coast, and Mayo Clinic Florida in the southeast). 
All of the sites, with the exception of Mayo Clinic Flor-
ida, had access to an emergency department observa-
tion unit in which protocols to provide care for patients 
with potential acute coronary syndrome existed as part 
of routine practice.
Participants
Eligible clinicians included all emergency physicians, 
nurse practitioners, and physician assistants caring for 
patients with chest pain. Eligible patients included 
adults (aged >17 years) presenting to the emergency 
department with a chief complaint of chest pain who 
were being considered by the treating clinician for 
admission to the observation unit for cardiac stress test-
ing or CCTA. Patients were excluded if they had isch-
emic changes on the initial ECG (eg, ST segment 
depression, T wave inversion, or new left bundle branch 
block), had an initial cardiac troponin level more than 
the 99th centile, had known coronary artery disease, 
had used cocaine in the past 72 hours (by history or test-
ing), had a prior plan for cardiac intervention or admis-
sion, had barriers to outpatient follow-up, were 
prisoners, were pregnant, were hearing or visually 
impaired, or were otherwise unable to use the decision 
aid. We classified patients deemed to meet the exclu-
sion criteria after randomization, but before the 
patient-clinician disposition discussion as post-ran-
domization exclusions.16
randomization and masking
Allocation was concealed by an online password pro-
tected randomization algorithm (Medidata Balance; 
Medidata Solutions, New York City, NY). Patients were 
randomized 1:1 and dynamically stratified17 by age, sex, 
and site because of the known associations of age and 
sex with cardiovascular risk, potential unmeasured dif-
ferences between sites, and the availability of these 
data at the time of enrollment. Clinicians were not ran-
domized. Patients, study coordinators, and treating cli-
nicians were not masked to allocation. All other 
investigators were blinded to allocation.
study treatments
Intervention
We sought to assist patients and clinicians in making a 
risk informed shared decision in the emergency setting 
in which patients typically do not have the opportunity 
to learn about their condition prior to the visit and clini-
cians often make decisions unilaterally to facilitate 
patient safety and rapid treatment of life threatening 
conditions. For these contextually specific reasons, we 
designed the decision aid for use during the clinical 
encounter.18  The decision aid was developed10  in Roch-
ester, Minnesota through a participatory action 
research methodology19  in which feedback was inten-
tionally and iteratively sought from patients, clinicians, 
an expert in healthcare design, and the investigative 
team and was field tested until thematic saturation was 
achieved. Prior to conducting the trial, we refined the 
decision aid to ensure contextual fit with each practice 
setting. Figure 1 shows the refined decision aid. At two 
of the sites, CCTA was available and frequently carried 
out in the evaluation of patients with possible acute 
coronary syndrome. For these two sites, the option of 
CCTA was added to the decision aid (see supplementary 
figure).
Delivery of the intervention
For patients randomized to the decision aid, a study 
coordinator collected each of the variables needed to 
populate the quantitative probability web tool,14  asked 
the treating clinician to sign off on their accuracy, and 
calculated the patient’s pretest probability of acute cor-
onary syndrome, incorporating the result of the first 
troponin test but prior to subsequent biomarker testing 
(fig 2). After selecting the decision aid corresponding to 
the appropriate level of risk, the study coordinator 
offered to provide the clinician with a concise refresher 
of the content. The treating clinician, after evaluating 
the patient and the results of the initial ECG and cardiac 
troponin tests, then used the decision aid to educate the 
patient about the results of the two tests, the potential 
need for observation and further cardiac testing, subse-
quent cardiac troponin testing to definitively rule out 
acute myocardial infarction, if required, and their 
the bmj | BMJ 2016;355:i6165 | doi: 10.1136/bmj.i6165
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2 What You Can DoA STRESS TEST, which views blood 
flow to your heart at rest and under stress
may be needed.
Examining your risk will help you and your 
clinician decide together whether or not 
you should have additional heart testing.
3Your Personal Risk Evaluation Your risk of having a heart or pre-heart 
attack within the next 45 days can be determined 
by comparing you to people with similar factors 2
who also came to the Emergency Department 
with chest pain.
4  Would you prefer to have a stress test during this emergency visit or decide 
later during an outpatient 
appointment?
    I would like to have a stress test during my 
emergency visit. I realize that this may increase 
the cost of my care and/or lengthen my stay.
  I would like to be seen by a heart doctor  
within 24-72 hours and would like assistance 
in scheduling this appointment.
  I would like to schedule an appointment on my 
own to consult with my primary care physician.
  I would like my Emergency Department doctor 
to make this decision for me.
What’s Next? 
1 Your Chest Pain Diagnosis  Your initial test results are NEGATIVE  
for a heart attack. These included:
 •  Blood tests to look for an enzyme called
troponin that is released when the heart
muscle is damaged. Additional troponin tests
may be done to monitor you for heart attack
during your emergency visit.
•  An electrocardiogram to check whether
your heart is getting enough oxygen
and blood.
However, the chest pain you are 
experiencing today may be a 
warning sign for a future heart attack.
Prepared for:
3
had a heart 
or a pre- heart 
attack within 
45 days of
their  Emergency
Department visit,
97 did not.
 
Of every  
100
people like you 
who came to  
the Emergency 
Department  
with chest pain...
1 Stress test options include nuclear stress testing, 
ultrasound stress testing, or exercise ECG 
(electrocardiogram) stress testing. Nuclear stress 
testing involves exposure to radiation which has been 
shown to be related to increased cancer risk over a 
lifetime. Your doctor can help you explore which option 
may be best for you.
2  • Age
• Gender
• Race
•  If chest pain is made worse when manual pressure
is applied to the chest area
•  If there is a history of coronary artery disease
• If the chest pain causes perspiration
•  Findings on electrocardiograms (electronic tracings of the heart)
• Initial cardiac troponin result
Fig 1 | Decision aid to facilitate discussion between clinicians and patients on whether to be admitted to an observation unit in the emergency 
department for cardiac stress testing or to follow up with a clinician in 24-72 hours
45 Day Post test Probabilities of ACS
INDICATIONS: The PreTest Consult instrument is intended for prescription use in a hospital, emergency
department or urgent care environment by competent health professionals. The PreTest Consult utilizes
clinical variables and ECG data to produce a numerical score that is the pretest probability of acute
cardiac ischemia or pulmonary embolism. It is intended to supplement, not substitute for the
physician’s decision-making process. The advice of PreTest Consult should be used as an aid to the
physician’s decision-making process for possible or suspected acute cardiac ischemia or pulmonary
embolism in conjunction with knowledge of the patient’s history, the results of a physical examination
and other clinical ndings.
>50
M
ACS Pretest Probability
Assessment ( Version 2.1Q)
CKMB (5ng/mL)
Troponin I (0.4ng/mL)
Troponin T (0.1ng/mL)
myoglobin (70ng/mL)
myoglobin & Troponin
2.1%
2%
2.3%
2%
0.9%
29%
21%
18.3%
17.0%
14.6%
Neg. Pos.
Age
Gender
Race
Chest Pain
Reproduced by
Palpation?
Personal History of
CAD?
Diaphoresis?
EKG ST Depression >
0.5mm?
T Wave Inversion
Deeper than -0.5?
TEST
Get Pretest Prob
African American
F
Yes
Print Results
No
Yes No
Yes No
Yes No
Yes No
Get Post Test Probs
Fig 2 | screen shot of quantitative pretest probability web tool. Figure displays 45 day probability of acute coronary syndrome for an african-american 
woman aged more than 50 years whose chest pain is not reproducible with palpation, is not diaphoretic, and there is no st segment depression greater 
than 0.5 mm or t wave inversion deeper than −0.5 mm, incorporating the result of the first cardiac troponin test. in this case, a coordinator would select a 
decision aid demonstrating a 3 out of 100 risk, rounding up from 2.3% to prioritize patient safety
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 personalized 45 day risk for acute coronary syndrome. 
The clinician then engaged the patient in selecting the 
management option most closely aligned to his or her 
values and preferences.
Usual care
For patients randomized to usual care, a study coordi-
nator instructed the clinician to discuss the results of 
diagnostic investigations and management options 
according to the clinician’s usual manner. Clinicians 
treating patients in the usual care arm did not have 
access to the quantitative probability web tool or to the 
decision aid. As the trial was intentionally pragmatic in 
design, usual care was not standardized.12
Data collection
We collected data documenting the screening process, 
randomization, and outcome assessment in compli-
ance with CONSORT guidelines.20  Data on patient 
knowledge of their risk for acute coronary syndrome 
and the available management options, decisional con-
flict, and patients’ trust in their physician were col-
lected by immediate post-visit survey.13  The 
clinician-patient discussion was video and audio 
recorded.21 Video and audio recordings were time 
stamped, and we determined the duration of the clini-
cian-patient discussion from these recordings. The 
recordings were uploaded to a secure server and deleted 
from the portable devices after upload. Access to the 
server was protected by a two step access: password 
protected access to all Mayo’s computers, and password 
protected access to the secure server. Audio and video 
files from facilities outside of Mayo Clinic were down-
loaded onto a password protected flash drive, sent to 
the prime site by secure courier, and uploaded to a 
secure server on receipt. We collected data on cardiac 
risk factors, post-emergency department management, 
and further cardiac investigations by review of the elec-
tronic medical record at each site.
Study coordinators contacted patients, starting at 45 
days after enrollment, to assess utilization and safety. 
Study coordinators made at least five attempts to con-
tact patients by phone for follow-up during different 
times of the day and on different days of the week. If 
patients were unable to be reached by phone or email 
and no subsequent visits in the electronic medical 
record were documented, mortality status was verified 
using Accurint, a national database frequently used by 
banks and other businesses to track individuals and 
ensure payment collection.22
Patient involvement
Patients seeking emergency care for chest pain, a 
patient adviser (MD), and a caregiver adviser (AL) were 
involved in the design of the study, the design of the 
intervention, submission of the application for funding, 
monitoring of study conduct, interpretation of the data, 
review of the manuscript for important intellectual con-
tent, and approval of the final manuscript for publica-
tion. When designing the trial, the patient adviser, 
caregiver adviser, and emergency department patient 
advisory council at the Saint Marys Hospital at Mayo 
Clinic provided input on the prioritization and selection 
of outcomes. As the primary purpose of the study was to 
educate and empower patients to participate in deci-
sions about their emergency care, the patient’s view-
point was prioritized over outcomes of potential interest 
to other stakeholders. Outcomes of interest to other key 
stakeholders were included as secondary outcomes. 
When designing the intervention, input was sought 
from the patient and caregiver advisers, the emergency 
department patient advisory council, and patients 
receiving emergency care for potential acute coronary 
syndrome regarding the clarity, helpfulness, and use-
fulness of the information included in the decision aid, 
and the decision aid was iteratively refined based on 
this input. As the patients and patient and caregiver 
advisers involved in the trial had no prior diagnosis of 
coronary artery disease and thus no engagement in a 
heart disease specific support group or organization, 
patient advisers were not directly involved in dissemi-
nation of the study findings. However, the patient and 
caregiver advisers were engaged at the highest level 
possible—partner—and included as co-investigators on 
the application for funding, members of the investiga-
tive steering committee, and assisted in interpretation 
of the data, review of the final manuscript for important 
intellectual content, and approval of the final manu-
script for submission, thus meeting the criteria for 
authorship and inclusion in the manuscript as co- 
authors.
Outcomes
Primary outcome
As the goal of research on patient centered outcomes is 
to provide patients and the public with the information 
they need to help them make decisions that affect their 
desired health outcomes,23  we prioritized the perspec-
tive of the patient over the perspectives of the other 
stakeholders in determining the primary outcome. 
During meetings with patient and caregiver advisers, 
knowledge about risk of acute coronary syndrome 
emerged as the outcome of greatest importance, so we 
selected patient knowledge as the primary outcome. As 
done in our pilot trial11  and in prior work,24 we assessed 
patient knowledge by immediate post-visit survey (see 
supplementary file).
Secondary outcomes
We measured the degree of uncertainty patients experi-
enced related to feeling uninformed about the manage-
ment options using the decisional conflict scale25  and 
patient trust in their clinician using the trust in physi-
cian scale.26  The decisional conflict scale includes 16 
items that are scored from 0-4; the items are summed, 
divided by 16, and then multiplied by 25. The scale is 
from 0-100, where higher scores are reflective of 
increased patient uncertainty about the choice. One 
study found that for every unit increase in decisional 
conflict scale scores, patients were 19% more likely to 
blame their doctor for bad outcomes.27  As such, a 1 unit 
change in decisional conflict scale score is considered 
the bmj | BMJ 2016;355:i6165 | doi: 10.1136/bmj.i6165
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clinically meaningful. The trust in physician scale con-
sists of nine items scored from 1-5; the items are sub-
tracted by 1, summed, divided by 9, and then multiplied 
by 25. The scale ranges from 0-100, where higher values 
are reflective of higher levels of patient trust in their 
physician. To the best of the authors’ knowledge, a clin-
ically meaningful change in trust in physician scale 
score has not been published. We surveyed participat-
ing patients and clinicians about the clarity and help-
fulness of the information shared and the acceptability 
of the decision aid using a 7 point Likert scale. Finally, 
five trained raters independently viewed videos of the 
patient-clinician discussion and assessed the degree to 
which clinicians engaged patients in the decision mak-
ing process using the observing patient involvement 
(OPTION) scale.21  This scale is composed of 12 items 
with a value of 0-4; they are summed, divided by 48, 
and then multiplied by 100. Scores range from 0-100, 
where higher scores are reflective of higher levels of 
patient engagement. Although a clinically meaningful 
change in OPTION scale score has not been defined, the 
mean score for outpatient clinicians in the original 
development investigation was 16.9 (SD 7.68).28 Given 
that the current trial was conducted in the emergency 
setting, in which time pressures and patient acuity 
often impact the clinician-patient interaction, we antic-
ipated OPTION scale scores in the current investigation 
to be lower than the originally published mean.
We assessed the acceptability of the decision aid by 
immediate post-visit survey.13 Patients in both the deci-
sion aid and usual care arms were asked to rate the 
amount, clarity, and helpfulness of the information 
they received and whether they would want to get infor-
mation in the same way and would recommend the way 
that they and their provider shared information about 
their chest pain symptoms and options for care. 
Responses were recorded using a 7 point Likert scale.
We assessed management by recording whether 
patients were admitted to the observation unit of the 
emergency department, admitted to hospital, or dis-
charged home; whether cardiac stress testing or CCTA 
were done; the results of testing; and whether the 
patient underwent percutaneous coronary intervention 
or coronary artery bypass grafting. The data were col-
lected by review of the electronic medical record at each 
participating site.
To assess safety we determined whether a patient 
experienced a major adverse cardiac event (MACE). 
Consistent with a consensus document on acute coro-
nary syndrome research in emergency departments,29 
we defined MACE as acute myocardial infarction,30 
death due to a cardiac or unknown cause, emergency 
revascularization, ventricular arrhythmia, or 
 cardiogenic shock. Potential MACEs were shared with 
the data safety monitoring board and discussed by the 
entire investigative team during monthly conference 
calls, and adjudicated based on consensus among site 
investigators. We excluded MACE occurring during the 
index visit to the emergency department or hospital, as 
these events were considered appropriately diagnosed 
during that visit. Events occurring after discharge 
home, which could have potentially been avoided, were 
classified as MACE. We collected data on all MACE 
occurring up to 45 days to be consistent with the 
 follow-up period used in the development of the quan-
titative pretest probability instrument,31  but we com-
pared 30 day event rates to comply with standardized 
reporting guidelines for emergency department risk 
stratification studies of patients with potential acute 
coronary syndrome.32 We plan to report the effect of 
the decision aid on healthcare utilization in a separate 
manuscript.
Clarification of primary outcome
The primary outcome registered at clinicaltrials.gov is 
the phrase “Test if Chest Pain Choice [the decision aid] 
safely improves validated patient-centered outcome 
measures” with the description “Test if the intervention 
significantly increases patient knowledge.” There is 
only one primary outcome for the study: patient knowl-
edge. The phrase “Test if Chest Pain Choice safely 
improves validated patient-centered outcome mea-
sures” refers to the five additional outcome measures 
listed as secondary outcomes at clinicaltrials.gov 
(a through e) and is redundant. This is documented in 
the study protocol,13 which was published prior to 
 completion of enrollment for the trial in August 2015.
statistical analysis
We estimated that 884 patients would provide 99% 
power to detect a 16% difference in patient knowledge 
between decision aid and usual care arms and 90% 
power to detect a 10% difference in the proportion of 
patients admitted to an observation unit for cardiac 
testing.13 To account for an estimated 5% potential loss 
to follow-up, we planned to enroll 930 patients. We 
summarized patient characteristics by study group and 
tested for differences between groups using t tests 
and χ2 tests. To test for differences in outcomes, we esti-
mated a series of regression models, each of which 
included indicators for study group. For continuous 
outcomes we used linear models, and for categorical 
outcomes we used multinomial (polytomous) logistic 
models. To account for non-independence of outcomes 
by site, we included indicators for study site in each 
model. We assessed for additional correlation within 
clinicians by estimating a hierarchical generalized 
model for each outcome and calculating the intra-clini-
cian correlation. All intra-clinician correlations were 
less than 1%, so we chose not to account for this correla-
tion in the final models. We followed the principle of 
intention to treat in the conduct of the trial and in all 
analyses.
Results
We assessed 3236 patients for eligibility from October 
2013 to August 2015 (fig 3 ). Overall, 361 clinicians partic-
ipated in the study. In total, 913 patients were random-
ized, with 13 post-randomization exclusions and two 
patients who withdrew consent, leaving 898 patients 
(451 in the decision aid arm, 447 in the usual care arm) 
in  the final analysis. In all 13 post-randomization 
doi: 10.1136/bmj.i6165 | BMJ 2016;355:i6165 | the bmj
RESEARCH
6
 exclusions, additional information became  available 
after randomization but before the patient-clinician dis-
position discussion indicating that the patient was not 
eligible. We audio or video recorded the patient-clini-
cian disposition discussion in 536 (59.7%) encounters. 
The main reasons recordings were not obtained were 
clinician and patient refusal and technical difficulties 
with recording equipment. We contacted 828 (92.2%, 
n=413 decision aid) patients by telephone or email for 
follow-up. Of the 70 (7.8%) remaining patients, 68 had 
mortality data available in the electronic medical record 
or Accurint,22 which confirmed that none of these 68 
patients died within 45 days. The two patients with miss-
ing mortality data were in the usual care arm.
Table 1 summarizes patient characteristics. The mean 
age was 50.3 (SD 14.5) years, and 534 (59.5%) partici-
pants were women. Most patients were white (n=531, 
59.1%) or black (n=309, 34.4%). For 285 (31.7%) partici-
pants the highest level of education was high school, 
general educational diploma, or less. There were no 
significant differences in baseline characteristics 
between the study arms.
Patient knowledge, decisional conflict, trust, and 
satisfaction
Patients randomized to the decision aid had greater 
knowledge (questions correct out of 8: decision aid, 
4.2 v usual care, 3.6; mean difference 0.66, 95% confi-
dence interval 0.46 to 0.86; table 2). A greater propor-
tion of patients in the decision aid arm correctly 
reported their exact pretest probability of acute coro-
nary syndrome and their risk within 10% of the correct 
value (decision aid, 65.0% v usual care, 18.1%; absolute 
difference 46.8%, 95% confidence interval 41.2% to 
52.5%). Patients in the decision aid arm reported sig-
nificantly less decisional conflict (decision conflict 
scale: decision aid, 43.5 (SD 15.3) v usual care, 46.4 (SD 
14.8); mean difference −2.9, −4.8 to −0.90). Use of the 
decision aid did not significantly impact patients’ trust 
in their physician. The proportion of patients who were 
“strongly satisfied” with the decision aid was not sig-
nificantly different between study arms (decision aid, 
49% v usual care, 43%; absolute difference 6%, 
P=0.06).
Patient participation and acceptability
Interobserver agreement between raters for OPTION 
scale assessments was 0.89 (95% confidence interval 
0.84 to 0.93). Patients randomized to the decision aid 
were more engaged in the decision making process, as 
indicated by higher OPTION scores (decision aid, 18.3 
(SD 9.4) v usual care, 7.9 (5.4); mean difference 10.3, 9.1 
to 11.5; table 2). Patients randomized to the decision aid 
found the information discussed to be of greater clarity, 
and a greater proportion (decision aid, 88.0% v usual 
care, 79.9%; absolute difference 8.1%, P=0.004) would 
recommend the way they discussed management 
options with their clinician to others.
Clinician acceptability
A greater proportion of clinicians in the decision aid 
arm found the information to be extremely helpful 
(table 2). Most (n=217, 62.7%) clinicians would recom-
mend the decision aid to others, and 62.9% (n=273) 
would want to use a decision aid for other decisions. 
The mean length of the discussion was 1.3 minutes 
 longer in the decision aid arm (decision aid, 4.4 (SD 
0.40) minutes v usual care, 3.1 (0.29) minutes; mean dif-
ference 1.3, P=0.008).
Management and 30 day outcomes
A significantly lower proportion of patients randomized 
to the decision aid decided, with their clinician, to be 
admitted to the emergency department observation 
unit for cardiac stress testing or CCTA (decision aid, 
37.3% v usual care, 52.1%; absolute difference 14.8%, 
95% confidence interval 1.1% to 13.9%), and a signifi-
cantly lower proportion underwent cardiac stress test-
ing within 30 days (decision aid, 38.1% v usual care, 
45.6%; 7.5%, 1.1% to 13.9%; table 3). There was no signif-
icant difference between arms in the proportion of 
patients who opted to follow up with a cardiologist or 
primary care provider and did not have a stress test or 
outpatient visit within 30 days (2/249 (0.8%) decision 
aid v 4/152 (2.6%) usual care; Fisher’s exact test P=0.20). 
Of those who underwent cardiac stress testing, a signifi-
cantly greater proportion of patients randomized to the 
decision aid had testing performed in the outpatient 
Allocated to usual care (n=455):
  Received allocated intervention (n=447)
  Post-randomization exclusions (n=7):
    New ischemia on ECG (n=2)
    Stress testing no longer being considered (n=1) 
    Initial troponin >99th centile (n=1)
    Known coronary artery disease (n=1)
  Patient withdrew consent (n=1)
Allocated to intervention (n=458):
  Received allocated intervention (n=451)
  Post-randomization exclusions (n=6):
    New ischemia on ECG (n=2)
    Stress testing no longer being considered (n=2) 
    Initial troponin >99th centile (n=1)
    Positive test for cocaine (n=1)
  Patient withdrew consent (n=1)
Contacted by phone or email at 45 days (n=415)
Mortality assessed by electronic medical
  record or Accurint  database (n=30)
Mortality status unable to be veried (n=2)
Contacted by phone or email at 45 days (n=413)
Mortality assessed by electronic medical
  record or Accurint  database (n=38)
Assessed for eligibility (n=3236)
Randomized (n=913) 
Included in nal analysis (n=447)
  Post visit patient surveys completed (n=442)
  Post visit clinician surveys completed (n=430)
  Recorded encounters included in videographic
    analysis (n=272)
Included in nal analysis (n=451)
  Post visit patient surveys completed (n=444)
  Post visit clinician surveys completed (n=436)
  Recorded encounters included in videographic
    analysis (n=264)
Excluded (n=2323):
  Not meeting inclusion criteria (n=2012):
    Known coronary artery disease (n=1034)
    Acute ischemia on initial electrocardiogram (ECG) (n=340)
    Unable to use decision aid (for example, learning barrier, dementia) (n=302)
    Troponin >99th centile (n=137)
    Cocaine use within 72 hours (n=65)
    Prior plan for cardiac intervention or admission (n=62)
    Barriers to outpatient follow-up (n=57)
    Prisoner (n=13)
    Pregnant (n=2)
  Patient refused to participate (n=166)
  Provider refused to participate (n=130)
  Other reasons (n=15)
Fig 3 | Participant flow diagram
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setting (decision aid, 30.2% v usual care, 17.2%; 13.1%, 
4.5% to 21.7%). The rate of coronary angiography, 
 coronary revascularization, admission to hospital, 
readmission to hospital, repeat emergency department 
visits, or outpatient clinic visits did not differ between 
study arms.
Four of the five patients with acute myocardial infarc-
tion and all cardiac interventions occurred during the 
index visit. Three of the four patients with acute myo-
cardial infarction in the decision aid arm had an initial 
troponin level less than the 99th centile, no acute isch-
emic changes on the initial ECG, and a subsequent 
increased troponin level detected on serial cardiac bio-
marker testing. These patients were admitted to the 
hospital for further evaluation and management and 
received a diagnosis of non-ST segment elevation myo-
cardial infarction. The fourth case of myocardial infarc-
tion in the decision aid arm occurred in a patient who 
had negative serial cardiac troponin results and no 
acute ischemic changes on the ECG but symptoms sug-
gestive of acute coronary syndrome. This patient was 
admitted to the hospital, underwent percutaneous cor-
onary intervention, and subsequently developed 
in-stent thrombosis. This in-stent thrombosis, which 
occurred in the hospital, was accompanied by increased 
troponin levels and ST segment elevation on ECG. The 
patient underwent a second percutaneous coronary 
intervention and recovered uneventfully.
table 1 | baseline characteristics of patients with low risk chest pain assigned to usual care or an aid for shared decision 
making. values are numbers (percentages) unless stated otherwise
Characteristic usual care (n=447) Decision aid (n=451)
Mean (SD) age (years) 50.6 (14.1) 50.0 (15.0)
Median (interquartile range) age (years) 51.0 (44.0-59.0) 51.0 (43.0-58.0)
Women 260 (58.2) 274 (60.8)
Race:
 American Indian/Alaska Native 4 (0.9) 4 (0.9)
 Asian 9 (2.0) 6 (1.3)
 Black or African-American 154 (34.5) 155 (34.4)
 Native Hawaiian or other Pacific Islander 0 (0.0) 2 (0.4)
 White 269 (60.2) 262 (58.1)
 Other 11 (2.5) 22 (4.9)
Annual income ($) (n=850):
 <20 000 84 (18.8) 92 (20.4)
 20 000-30 000 39 (8.7) 36 (8.0)
 30 000-40 000 46 (10.3) 44 (9.8)
 40 000-60 000 65 (14.5) 56 (12.4)
 60 000-80 000 59 (13.2) 58 (12.9)
 80 000-100 000 37 (8.3) 50 (11.1)
 >100 000 93 (20.8) 100 (22.2)
Highest level of education completed (n=881):
 High school or less 38 (8.5) 47 (10.4)
 High school or graduate education diploma 109 (24.4) 91 (20.2)
 College or vocational school 157 (35.1) 150 (33.3)
 College graduate (4 years) 82 (18.3) 98 (21.7)
 Graduate degree 54 (12.1) 55 (12.2)
Literacy screening questions (often/always):
 Need help reading medical instructions? 36 (8.1) 44 (9.8)
 Confident filling out medical forms? 358 (80.1) 375 (83.1)
 Have difficulty understanding written information about your medical condition? 28 (6.3) 40 (8.9)
Mean (SD) subjective numeracy scale score* 4.3 (1.1) 4.2 (1.1)
Median (interquartile range) numeracy 4.4 (3.5-5.1) 4.4 (3.4-5.1)
Hypertension 202 (45.1) 198 (43.9)
Dyslipidemia 137 (30.6) 114 (25.3)
Diabetes mellitus 71 (15.8) 61 (13.5)
Family history of cardiac disease 182 (40.6) 176 (39.0)
Smoking (current, recent cessation, or former) 165 (36.8) 181 (40.1)
Renal insufficiency 9 (2.0) 7 (1.6)
History of stroke or transient ischemic attack 16 (3.6) 18 (4.0)
Mean (SD) duration of chest pain (hours) 3.3 (5.5) 3.1 (5.0)
Median (interquartile range) duration of chest pain (hours) 1.0 (0.3-4.0) 1.0 (0.2-3.5)
Mean (SD) probability of ACS† 3.8 (4.3) 3.6 (3.7)
Median (interquartile range) probability of ACS 2.8 (0.6-5.2) 2.8 (0.6-5.2)
Friend or family member present 244 (54.6) 257 (57.0)
$1.0 (£0.8; €0.9).
ACS=acute coronary syndrome.
*McNaughton et al.41
†Calculated from quantitative probability web tool.
doi: 10.1136/bmj.i6165 | BMJ 2016;355:i6165 | the bmj
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No deaths of cardiac or unknown cause occurred in 
either arm. One patient in the decision aid arm was classi-
fied as having a MACE. This patient decided with their cli-
nician to be admitted to the hospital and underwent 
nuclear perfusion stress testing as an inpatient. The test 
result was interpreted as negative. The patient was dis-
charged from hospital but subsequently developed recur-
rent chest pain and returned to the emergency department 
within 30 days of hospital discharge with a non-ST seg-
ment myocardial infarction. The data safety monitoring 
board classified this MACE as unrelated to the intervention.
discussion
In patients with chest pain who were otherwise being 
considered for admission to an observation unit and 
advanced cardiac testing, shared decision making facili-
tated by a decision aid increased patient knowledge and 
patient engagement, decreased decisional conflict, and 
did not significantly affect trust in physicians. The deci-
sion aid was found to be acceptable to both patients and 
physicians, and its use, which took an average of one 
additional minute of clinician time, decreased the rate of 
admission to an observation unit for advanced cardiac 
testing and cardiac stress testing within 30 days of the 
emergency department visit. No major adverse cardio-
vascular events (MACEs) were related to the intervention.
Meaning of the study
Findings from this trial suggest that patients can be 
effectively educated and engaged in the emergency care 
setting in decisions about testing and follow-up and 
that it is feasible to do so in the flow of clinical care. In 
addition, when risk estimates from validated prediction 
models are shared with patients, and patients are 
invited to apply their informed values and preferences 
to decisions, rates of admission and testing did not 
increase. Rather, patient centered interventions such as 
those tested in this trial indicate that patients, when 
educated and informed of their risk, might choose with 
their clinician to undergo less extensive evaluation 
more closely tailored to their personalized risk. 
Although we observed less extensive evaluation in this 
trial, use of shared decision making in other scenarios 
in which lower utilization occurs than that observed in 
the US might not have similar results. However, health 
policy and clinical protocols that encourage transpar-
ent communication of risk and patient engagement in 
care decisions have potential to right-size testing to dis-
ease risk in a way that is acceptable to patients, clini-
cians, and policy makers. The findings from this trial 
are also timely, given health policy33  calling for compar-
ative effectiveness research to assist patients, clini-
cians, purchasers, and policy makers to make more 
informed healthcare decisions, and the increased focus 
on patient centered outcomes research at a national 
and international level.34 To our knowledge, this is the 
first multicenter trial testing the effect of a shared deci-
sion making intervention in the emergency setting.
limitations and strengths of this study
Several limitations of this trial should be taken into con-
sideration. The quantitative pretest probability web 
tool8 9 only applies to patients with chest pain. As such, 
the decision aid cannot be used in patients with potential 
acute coronary syndrome who present with non-chest 
pain syndromes (eg, shortness of breath, diaphoresis). In 
addition, more accurate methods to estimate patient 
risk, such as those incorporating high sensitivity tropo-
nin C assays, are likely to become available. In the future 
it might be preferable to generate risk estimates with 
these methods and select the decision aid that corre-
sponds to this level of risk. We used two versions of the 
decision aid in the trial—one that included the option of 
coronary computed tomography angiography (CCTA) 
and one that included only cardiac stress testing. 
Although this introduced a degree of heterogeneity in the 
table 2 | effect of decision aid on patient knowledge, decisional conflict, trust in 
physician, patient involvement in decision, and acceptability of the decision aid. values 
are numbers (percentages) unless stated otherwise
Outcome
usual care 
(n=447)
Decision aid 
(n=451)
Mean difference 
(95% Ci) or P value
Patient knowledge
Eight knowledge questions 3.6 (1.5) 4.2 (1.5) 0.66 (0.46 to 0.86)
Correctly assessed 45 day risk for ACS 2 (0.4) 10 (2.2) 0.039
Correctly assessed 45 day risk for ACS within 10% 81 (18.1) 293 (65.0) <0.001
Decisional conflict and trust
Decisional conflict scale 46.4 (14.8) 43.5 (15.3) -2.9 (-4.8 to -0.90)
Trust in physician scale 87.7 (16.0) 89.5 (13.4) 1.7 (-0.2 to 3.6)
Patient involvement in decision
OPTION scale (n=536) 7.9 (5.4) 18.3 (9.4) 10.3 (9.1 to 11.5)
Patient acceptability
Amount of information:
 Too little (1-2) 24 (5.5) 12 (2.7)
0.133 Just right (3-5) 401 (91.6) 416 (94.3)
 Too much (6-7) 13 (3.0) 13 (2.9)
Clarity of information:
 Not clear at all (1-2) 5 (1.1) 7 (1.6)
0.011 Somewhat clear (3-5) 137 (31.3) 98 (22.3)
 Extremely clear (6-7) 296 (67.6) 335 (76.1)
Helpfulness of the information:
 Not helpful at all (1-2) 10 (2.3) 7 (1.6)
0.506 Somewhat helpful (3-5) 125 (28.5) 114 (25.9)
 Extremely helpful (6-7) 303 (69.2) 320 (72.6)
Would recommend to others:
 Yes (1-2) 349 (79.9) 387 (88.0)
0.004 Not sure (3-5) 77 (17.6) 44 (10.0)
 No (6-7) 11 (2.5) 9 (2.0)
Would want to use for other decisions:
 Yes (1-2) 335 (76.7) 346 (78.6)
0.813 Not sure (3-5) 83 (19.0) 77 (17.5)
 No (6-7) 19 (4.3) 17 (3.9)
Clinician acceptability
Helpfulness of the information:
 Not helpful at all (1-2) 13 (3.1) 24 (5.5)
<0.001 Somewhat helpful (3-5) 265 (63.2) 175 (40.3)
 Extremely helpful (6-7) 141 (33.7) 235 (54.1)
Would recommend to others:
 Yes (1-2) 175 (41.9) 271 (62.7)
<0.001 Not sure (3-5) 234 (56.0) 148 (34.3)
 No (6-7) 9 (2.2) 13 (3.0)
Would want to use for other decisions:
 Yes (1-2) 183 (43.8) 273 (62.9)
<0.001 Not sure (3-5) 229 (54.8) 148 (34.1)
 No (6-7) 6 (1.4) 13 (3.0)
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intervention, the trial was intentionally pragmatic in 
design, and contextual fit of the decision aid to facilitate 
clinician-patient discussions relevant to the clinical set-
tings enrolling patients in the trial was essential. In addi-
tion, evidence now supports application of the shared 
decision making tool in clinical care contexts where 
CCTA is frequently used and in practice settings where 
cardiac stress testing is more commonly used. We ran-
domized at the patient level, increasing the risk of con-
tamination between intervention and control groups. To 
limit the risk of contamination, the quantitative pretest 
probability web tool was password protected, and coor-
dinators did not provide clinicians access to the decision 
aid. However, even if contamination were to occur, this 
would bias the results of the trial toward the null, and we 
observed a positive effect of the intervention despite the 
potential for contamination. Although we reviewed elec-
tronic medical records and attempted to contact all 
enrolled patients, we were unable to contact 70 (8%) for 
assessment of a secondary outcome. Of these, 68 were 
confirmed alive at 45 days. The 92% phone follow-up rate 
supplemented by mortality review from a national data-
base is, however, robust and comparable to other high 
quality studies of patients in the emergency department 
setting with potential acute coronary syndrome. We were 
unable to obtain video recordings in 40% of the encoun-
ters. However, the 536 video recordings that were 
obtained exceeded the required sample size of 221 
needed to meet power estimates. The study had 78% 
power to detect a 5% difference in MACEs between study 
arms, using a one sided non-inferiority test with an α of 
0.05. Although this was substantially greater power than 
the initial cohort of patients recruited in our single center 
pilot trial, greater power and precision would be optimal. 
It is critical that evidence based local practice protocols 
to definitively rule out acute myocardial infarction with 
serial cardiac troponin tests be reliably followed in all 
patients, regardless of the decision to undergo further 
cardiac stress testing during the index emergency depart-
ment visit or to follow-up as an outpatient. This is high-
lighted by the fact that four patients in the decision aid 
group and one patient in the usual care group were diag-
nosed as having acute myocardial infarction during their 
index presentation. Although no patients in this trial 
were ruled out for acute myocardial infarction using 
serial cardiac troponin results, were discharged home 
from the hospital without further testing, or subse-
quently experienced an acute myocardial infarction 
before follow-up as an outpatient, this scenario is possi-
ble, and a large scale implementation trial is needed to 
definitively assess safety.
implications for practice and policy
The decision aid frames the decision for the patient, 
provides standardized terminology, and transparently 
communicates patient risk and the available manage-
ment options in a manner that many clinicians might 
find difficult to reproduce without use of the decision 
aid. Patient centered decision support interventions 
such as these are designed to facilitate higher quality 
conversations with patients than typically occur in con-
temporary emergency care. Moreover, the results of this 
trial invite clinicians to consider whether our current 
perception of the degree to which patients are engaged 
in decision making as part of usual practice respects 
patient autonomy and supports interaction with profes-
sional judgment.
We recommend clinicians consider using the deci-
sion aid in patients who present with acute chest pain, 
no known history of coronary artery disease, and initial 
negative electrocardiogram and troponin test results, 
and for whom the clinician is considering further car-
diac investigations such as cardiac stress testing or 
CCTA. The clinician can obtain an estimate of the 
patient’s 45 day pretest probability for acute coronary 
syndrome and download the decision aid correspond-
ing to the appropriate level of risk at http://shareddeci-
sions.mayoclinic.org/decision-aid-information/
chest-pain-choice-decision-aid/.Write the patient’s 
name in the top left corner, and give the decision aid to 
the patient for subsequent review. The discussion on 
shared decision making should also be documented in 
the medical record. Depending on the local practice set-
ting, the decision aid can be used by the clinician with 
a specific patient who meets these criteria or might be 
implemented in the context of a comprehensive risk 
stratification protocol for patients in the emergency 
department with potential acute coronary syndrome.
As support for, and interest in, shared decision mak-
ing in the context of emergency care delivery has 
increased,35 36  questions have arisen about how this 
might affect liability risk.37  Unfortunately, the relation 
between shared decision making and liability risk can-
not be assessed as it is clouded by variation in the 
table 3 | Management and 30 day outcomes
Characteristic
usual care 
(n=447)
Decision aid 
(n=451) P value
Shared management decision:
 Observation unit admission for stress testing or CCTA 225 (52.1) 165 (37.3)
<0.001
 Follow up with a cardiologist 52 (12.0) 101 (22.9)
 Follow up with a primary care physician 100 (23.1) 138 (31.2)
 Have emergency physician decide 55 (12.7) 38 (8.6)
Cardiac stress test performed within 30 days 204 (45.6) 172 (38.1) 0.013
Outpatient stress testing: 35 (17.2) 52 (30.2) 0.001
 Exercise treadmill testing 65 (31.9) 44 (25.6) 0.779
 Stress echocardiography 86 (42.2) 81 (47.1)
 Nuclear perfusion testing 39 (19.1) 37 (21.5)
 Other 14 (6.9) 10 (5.8)
CCTA performed within 30 days 80 (17.9) 63 (14.0) 0.111
Coronary revascularization 4 (0.9) 7 (1.6) 0.366
Percutaneous coronary intervention 3 (75.0) 6 (85.7)
Coronary artery bypass grafting 1 (25.0) 1 (14.3)
Admitted to hospital from ED observation unit 22 (4.9) 22 (4.9) 0.990
Repeat ED visit 39 (9.3) 52 (12.5) 0.156
Readmission to hospital 19 (4.5) 20 (4.8) 0.884
Outpatient clinic visit 259 (62.0) 266 (64.1) 0.568
Cardiac events:
 Acute myocardial infarction 1 (0.2) 4 (0.9) 0.215
 Death of cardiac or unknown cause 0 (0.0) 0 (0.0) 1.00
 MACE within 30 days* 0 (0.0) 1 (0.2) 0.998
CCTA=coronary computed tomography angiography; ED=emergency department; MACE=.major adverse cardiac event.
*Excluding the index event.
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meaning and implementation of shared decision mak-
ing.38  While use of shared decision making might 
decrease clinician’s liability risk by improving the 
patient-clinician relationship, enhancing communica-
tion (which is often at the root of lawsuits brought 
against clinicians after an adverse outcome39 ), and 
decreasing the frequency of invasive procedures,40 
shared decision making might increase liability risk if 
the care agreed on by the patient and clinician is sensi-
ble but perhaps at odds with what other clinicians 
would have selected without patient input, as the latter 
is often used to determine “standard of care.”
unanswered questions and future research
To date, no shared decision making interventions have 
been made routine and incorporated into clinical proto-
cols and emergency care delivery. While the findings from 
this multicenter trial suggest that the decision aid might be 
effective across a variety of clinical settings, further imple-
mentation studies are needed to determine how best to 
incorporate it in care pathways, how emergency clini-
cians, cardiologists, and primary care clinicians can best 
work together to ensure incorporation and implementa-
tion of informed patient preferences into admission, test-
ing, and follow-up decisions, and how to ensure patient 
preferences guide decision making both during and after 
the emergency department encounter. In addition, as time 
for clinician-patient interaction in the emergency setting is 
limited and levels of healthcare literacy between patients 
vary, time efficient approaches to patient activation that 
involve education and preparation for engagement in 
shared decisions with clinicians, such as a brief standard-
ized video, should be explored. Interventions designed to 
ensure communication of the rationale for care decisions 
to family members who were not present during the emer-
gency department encounter are also needed to ensure 
effective implementation of the care decisions made. 
Healthcare policy to encourage, and perhaps incentivize, 
risk communication and that incorporates informed 
patient preferences in emergency care decisions about 
testing and follow-up might also be needed to align finan-
cial incentives with the best interests of patients. Finally, a 
large scale implementation trial might be needed to more 
definitively test the safety of the intervention.
Conclusion
Use of a decision aid in patients with low risk chest pain 
who were otherwise being considered for admission to 
an observation unit for cardiac stress testing or CCTA 
increased patient knowledge and patient engagement 
and decreased decisional conflict. Shared decision 
making facilitated by the decision aid was perceived to 
be acceptable to both patients and physicians, and its 
use decreased the proportion of patients admitted to 
the observation unit for cardiac testing, with no adverse 
events related to the intervention.
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